[1]
Anand, M., Randhawa, G.K. and Salwan, S.K. 2023. A prospective, randomised, open label study to compare efficacy and safety of hydroxychloroquine and teneligliptin in patients of type 2 diabetes mellitus refractory to concomitant metformin and glimepiride. International Journal of Basic & Clinical Pharmacology. 12, 2 (Feb. 2023), 192–198. DOI:https://doi.org/10.18203/2319-2003.ijbcp20230385.